What is Barrington Research's Forecast for DLB Q4 Earnings?

Dolby Laboratories, Inc. (NYSE:DLB - Free Report) - Research analysts at Barrington Research upped their Q4 2025 EPS estimates for shares of Dolby Laboratories in a report released on Thursday, January 30th. Barrington Research analyst P. Sholl now expects that the electronics maker will post earnings per share of $0.53 for the quarter, up from their prior forecast of $0.49. Barrington Research currently has a "Outperform" rating and a $100.00 price target on the stock. The consensus estimate for Dolby Laboratories' current full-year earnings is $2.92 per share.

A number of other analysts have also recently issued reports on the company. Rosenblatt Securities reissued a "buy" rating and issued a $100.00 target price on shares of Dolby Laboratories in a research report on Thursday, January 30th. StockNews.com downgraded Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a report on Friday, January 31st.

Dolby Laboratories Stock Performance

NYSE DLB traded up $0.05 during trading hours on Monday, hitting $84.50. The company had a trading volume of 392,207 shares, compared to its average volume of 485,379. The business has a 50 day moving average of $79.76 and a 200-day moving average of $75.87. Dolby Laboratories has a 1-year low of $66.35 and a 1-year high of $89.66. The company has a market cap of $8.06 billion, a PE ratio of 31.07 and a beta of 0.98.

Dolby Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, February 19th. Investors of record on Tuesday, February 11th will be issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.56%. The ex-dividend date of this dividend is Tuesday, February 11th. Dolby Laboratories's dividend payout ratio is currently 48.53%.

Insider Buying and Selling

In other Dolby Laboratories news, CAO Ryan Nicholson sold 7,000 shares of the business's stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $84.07, for a total value of $588,490.00. Following the transaction, the chief accounting officer now directly owns 29,758 shares of the company's stock, valued at approximately $2,501,755.06. The trade was a 19.04 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Peter C. Gotcher sold 6,079 shares of the firm's stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $78.96, for a total transaction of $479,997.84. Following the completion of the sale, the director now owns 37,593 shares of the company's stock, valued at $2,968,343.28. This trade represents a 13.92 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 182,917 shares of company stock valued at $14,861,429 over the last quarter. 38.39% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Dolby Laboratories

Several institutional investors and hedge funds have recently added to or reduced their stakes in DLB. Bank of New York Mellon Corp lifted its holdings in shares of Dolby Laboratories by 64.2% in the 4th quarter. Bank of New York Mellon Corp now owns 4,826,477 shares of the electronics maker's stock valued at $376,948,000 after buying an additional 1,887,518 shares during the period. State Street Corp boosted its position in shares of Dolby Laboratories by 1.5% during the 3rd quarter. State Street Corp now owns 1,931,586 shares of the electronics maker's stock worth $147,824,000 after purchasing an additional 29,289 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Dolby Laboratories by 4.3% during the 3rd quarter. Geode Capital Management LLC now owns 1,538,583 shares of the electronics maker's stock worth $117,767,000 after purchasing an additional 63,293 shares in the last quarter. Disciplined Growth Investors Inc. MN grew its stake in shares of Dolby Laboratories by 4.5% during the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 1,466,212 shares of the electronics maker's stock worth $112,209,000 after purchasing an additional 63,589 shares during the period. Finally, Boston Trust Walden Corp increased its holdings in shares of Dolby Laboratories by 0.9% in the 4th quarter. Boston Trust Walden Corp now owns 1,084,700 shares of the electronics maker's stock valued at $84,715,000 after purchasing an additional 9,624 shares in the last quarter. Institutional investors and hedge funds own 58.56% of the company's stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.